wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34616440-3A604807-8A4B-4848-A0FC-1D6B97E822C8
Q34616440-3A604807-8A4B-4848-A0FC-1D6B97E822C8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34616440-3A604807-8A4B-4848-A0FC-1D6B97E822C8
Development of second-generation VEGFR tyrosine kinase inhibitors: current status.
P2860
Q34616440-3A604807-8A4B-4848-A0FC-1D6B97E822C8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34616440-3A604807-8A4B-4848-A0FC-1D6B97E822C8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4404f51673a9a733029b10ddfc24bb02ded8a327
P2860
Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results